Company: Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. : [MLNM
Loading...
()
]
]
Pharma heavyweights Eli Lilly and Bristol Meyers Squibb report earnings, with CNBC's Mike Huckman
Wyeth CEO Bernard Poussot discusses his company's earnings and outlook with CNBC's Maria Bartiromo.
A "dear doctor" letter was sent out to warn doctors of possible problems with Vytorin. CNBC's Mike Huckman has the details.
A JAMA study shows Pfizer's Viagra helps female sexual function, reports CNBC's Mike Huckman.
Drugmaker Roche offers to acquire all outstanding Genentech shares, with Franz Humer, Roche chairman
The word cancer being mentioned in the same breath as a cholesterol-lowering drug has investors in Merck and Schering-Plough running for the...
Opportunities in the pharma space, with Fast Money's Pete Najarian, of Najarian Capital
Vytorin did not meet main goals in new study, reports CNBC's Mike Huckman
Roche will have to up its offer price in order to buy Genentech, but it's tough to speculate on what the right price is, Christophe Eggmann ...
Swiss drug giant Roche makes a play for all of Genentech and a look at earnings for the pharma sector, with CNBC's Mike Huckman
Roche offers to buy the rest of Genentech for $43.7B, reports CNBC's David Faber
Roche's offer to buy out Genentech appears to be a good deal, financially and pharmaceutically, according to Dr. Keither Schlagbauer from Fr...
Genentech shareholders probably won't be too happy with the bid price from Roche and there might be higher offers to come, Birgit Kulhoff fr...
Swiss drugmaker Roche Holding offered to buy all the outstanding shares in its US partner Genentech Monday. Peter McDougall, CEO of Druganal...
Roche offered to buy all outstanding shares in Genentech for $43.7 billion Monday. Franz B. Humer, chairman of Roche, discusses the deal.
A look at whether the pharma sector is ripe for consolidation, with CNBC's Mike Huckman
Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big wave of consolidation...
Posts |
COMPANY : Millennium
10 Apr 2008
Following are the day’s biggest winners and losers... Read More
10 Apr 2008
This morning there's a plethora of stuff to blog about: the Takeda-Millennium deal, more commentary about Merck and Schering-Plough and the extent of the Vytorin/Zetia fallout, Genentech's biotech bellweather earnings after the closing bell today, just to name a few... Read More
7 Jan 2008
Here's our Fast Money Final Trade... Read More
News |
COMPANY : Millennium
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes